title: Secondary arterial hypertension: when, who, and how to screen?
abstract: Secondary hypertension refers to arterial hypertension due to an identifiable cause and affects ∼5-10% of the general hypertensive population. Because secondary forms are rare and work up is time-consuming and expensive, only patients with clinical suspicion should be screened. In recent years, some new aspects gained importance regarding this screening. In particular, increasing evidence suggests that 24 h ambulatory blood pressure (BP) monitoring plays a central role in the work up of patients with suspected secondary hypertension. Moreover, obstructive sleep apnoea has been identified as one of the most frequent causes. Finally, the introduction of catheter-based renal denervation for the treatment of patients with resistant hypertension has dramatically increased the interest and the number of patients evaluated for renal artery stenosis. We review the clinical clues of the most common causes of secondary hypertension. Specific recommendations are given as to evaluation and treatment of various forms of secondary hypertension. Despite appropriate therapy or even removal of the secondary cause, BP rarely ever returns to normal with long-term follow-up. Such residue hypertension indicates either that some patients with secondary hypertension also have concomitant essential hypertension or that irreversible vascular remodelling has taken place. Thus, in patients with potentially reversible causes of hypertension, early detection and treatment are important to minimize/prevent irreversible changes in the vasculature and target organs.
authors.affiliation: Department of Cardiology, Inselspital, University Hospital, Bern, Switzerland.
authors.forename: Stefano F
authors.initials: SF
authors.lastname: Rimoldi
authors.affiliation: Department of Cardiology, Inselspital, University Hospital, Bern, Switzerland Facultad de Ciencias, Departamento de Biología, Universidad de Tarapacá, Arica, Chile.
authors.forename: Urs
authors.initials: U
authors.lastname: Scherrer
authors.affiliation: Division of Cardiology, St Luke's-Roosevelt Hospital Center, New York, NY, USA messerli.f@gmail.com.
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
mesh_terms: D000367:Age Factors; D000959:Antihypertensive Agents / Q000627:therapeutic use; D018660:Blood Pressure Monitoring, Ambulatory; D003937:Diagnosis, Differential; D042241:Early Diagnosis; D004452:Echocardiography; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D018579:Patient Selection
chemical_list: D000959:Antihypertensive Agents
keywords: Arterial hypertension; Obstructive sleep apnoea; Pheochromocytoma; Primary aldosteronism; Renal artery stenosis; Secondary hypertension